BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31793218)

  • 81. Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL).
    Bahri R; Boyer F; Halabi MA; Chaunavel A; Feuillard J; Jaccard A; Ranger-Rogez S
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740565
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical Features of Intestinal Ulcers Complicated by Epstein-Barr Virus Infection: Importance of Active Infection.
    Liu Y; Li Y; Li Y; Wu S; Tian X; Tang T; Sun H; He C
    Dis Markers; 2021; 2021():6627620. PubMed ID: 34007344
    [TBL] [Abstract][Full Text] [Related]  

  • 83. T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma.
    Vrsalovic MM; Korac P; Dominis M; Ostojic S; Mannhalter C; Kusec R
    Hematol Oncol; 2004 Dec; 22(4):169-77. PubMed ID: 16134192
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan.
    Hirose Y; Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawabata H; Fukushima T; Ogawa N; Wano Y; Umehara H
    Eur J Haematol; 2006 Feb; 76(2):109-18. PubMed ID: 16405431
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study.
    Hong H; Fang X; Wang Z; Huang H; Lam ST; Li F; Peng C; Tian Y; Lin S; Lin T
    Leuk Lymphoma; 2018 Dec; 59(12):2911-2916. PubMed ID: 29909754
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
    Koh YW; Han JH; Yoon DH; Suh C; Huh J
    Hematol Oncol; 2018 Feb; 36(1):182-188. PubMed ID: 28744882
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

  • 89. B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma.
    Shang Y; Fu X; Chang Y; Li Y; Zhang M
    Sci Rep; 2018 Aug; 8(1):12907. PubMed ID: 30150635
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies.
    Li J; Zhu X; Deng X; Zhang W; Jiang Y; Wan Y; Chen J; Li C; Liu W; Zhao S; Su X
    Am J Clin Pathol; 2023 Apr; 159(4):379-394. PubMed ID: 36880300
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
    Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
    Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
    Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
    J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
    Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
    Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
    [TBL] [Abstract][Full Text] [Related]  

  • 97. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
    Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
    Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A novel prognostic model for angioimmunoblastic T-cell lymphoma: A retrospective study of 55 cases.
    Sun J; He S; Cen H; Zhou D; Li Z; Wang MY; Ke Q; Guo BP; Liao CC; Rong C; Zhong DN; Tan XH
    J Int Med Res; 2021 May; 49(5):3000605211013274. PubMed ID: 34034561
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
    Takahashi T; Maruyama R; Mishima S; Inoue M; Kawakami K; Onishi C; Miyake T; Tanaka J; Nabika T; Ishikura H
    J Clin Exp Hematop; 2010; 50(1):59-63. PubMed ID: 20505277
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
    Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
    Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.